Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00889577 · ClinicalTrials.gov registry record
Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons
A clinical trial, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Completed
- Registry status
- 233
- Enrollment target
NCT00889577: Completed study, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
NCT00889577 is a clinical trial that has completed, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 233 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00889577 has completed, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- COMPLETED
- Registry status
- 233 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate the association between nonalcoholic fatty liver disease (NAFLD) by computed tomography (CT) scan and coronary artery disease (CAD) measured by the calcium (CAC) score among HIV-infected persons.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-12 |
What the finished NCT00889577 record still lists
NCT00889577 is an observational study that tracks outcomes without assigning an intervention. The registered 233 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00889577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00889577 about?
NCT00889577 is a clinical study titled "Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons". The primary purpose of this study is to evaluate the association between nonalcoholic fatty liver disease (NAFLD) by computed tomography (CT) scan and coronary artery disease (CAD) measured by the calcium (CAC) score among HIV-infected persons.
What is the current status of trial NCT00889577?
This trial is currently completed. The enrollment target is 233 participants. The study started on 2008-12. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT00889577?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06993844 · 233 participants · Phase 1
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- NCT07141706 · 233 participants · Phase 1
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia